Advertisement

Topics

Genmab A/S: Genmab Achieves USD 25 Million Milestone for First Commercial Sale of DARZALEX (daratumumab) in Japan and Updates Financial Guidance

14:52 EST 14 Nov 2017 | FinanzNachrichten

Company Announcement -- First commercial sale of DARZALEX in Japan triggers USD 25 million in milestone payments from Janssen -- Financial guidance updatedCopenhagen, Denmark; November 14, 2017 - G...

Original Article: Genmab A/S: Genmab Achieves USD 25 Million Milestone for First Commercial Sale of DARZALEX (daratumumab) in Japan and Updates Financial Guidance

NEXT ARTICLE

More From BioPortfolio on "Genmab A/S: Genmab Achieves USD 25 Million Milestone for First Commercial Sale of DARZALEX (daratumumab) in Japan and Updates Financial Guidance"

Advertisement
Quick Search
Advertisement
Advertisement